计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| T414465-25mg |
25mg |
期货 ![]() |
| |
| T414465-100mg |
100mg |
现货 ![]() |
| |
| T414465-250mg |
250mg |
现货 ![]() |
| |
| T414465-1g |
1g |
期货 ![]() |
|
| 别名 | 本维莫德 | (E)-2-异丙基-5-苯乙烯基苯-1,3-二醇 | 2-异丙基-5-[(E)-2-苯基乙烯基]-1,3-苯二醇 |
|---|---|
| 英文别名 | 5-((1E)-2-PHENYLETHEN-1-YL)-2-(PROPAN-2-YL)BENZENE-1,3-DIOL | Tapinarof (USAN) | 5-[(1E)-2-Phenylethen-1-yl]-2-(propan-2-yl)benzene-1,3-diol | GTPL9686 | AKOS025296109 | s9700 | TAPINAROF [INN] | BCP13569 | Sinefunginum [INN-Latin] | 2-Isopropyl-5-styrylb |
| 规格或纯度 | Moligand™, ≥99% |
| 英文名称 | Tapinarof |
| 生化机理 | Tapinarof(GSK2894512,Benvitimod,WBI 1001,DHPS,DMVT 505)是芳基烃受体(AhR)的天然激动剂,能诱导永生化角质细胞(HaCaT)中 AhR 的核转位,其 EC50 为 0.16 nM。Tapinarof 能以剂量依赖性方式诱导 CD4+ T 细胞凋亡,IC50 为 5.2 μM。 |
| 储存温度 | 避光,-20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 激动剂 |
| 作用机制 | 芳香烃受体激动剂 |
| 产品介绍 |
Information Tapinarof Tapinarof (GSK2894512, Benvitimod, WBI 1001, DHPS, DMVT 505) is a natural agonist of aryl hydrocarbon receptor (AhR) and induces nuclear translocation of AhR in immortalized keratinocytes (HaCaT) with EC50 of 0.16 nM. Tapinarof induces cellular apoptosis in CD4+ T cells in a dosedependent manner with IC50 of 5.2 μM. Targets AhR (in immortalized keratinocytes); apoptosis (in CD4+ T cells) 0.16 nM(EC50); 5.2 μM In vitro Tapinarof binds and activates AhR in multiple cell types, including cells of the target tissue –human skin. In addition, tapinarof moderates proinflammatory cytokine expression in stimulated peripheral blood CD4+ T cells and ex vivo human skin, and impacts barrier gene expression in primary human keratinocytes; both of these processes are likely to be downstream of AhR activation based on current evidence. In vivo The anti-inflammatory properties of tapinarof derive from AhR agonism is conclusively demonstrated using the mouse model of imiquimod-induced psoriasiform skin lesions. Topical treatment of AhR-sufficient mice with tapinarof leads to compound-driven reductions in erythema, epidermal thickening and tissue cytokine levels. In contrast, tapinarof has no impact on imiquimod-induced skin inflammation in AhR-deficient mice. Cell Research(from reference) Cell lines:HaCaT cells Concentrations:0.01 pM - 1 μM Incubation Time:30 min |
| 纯度 | ≥99% |
| ALogP | 4.526 |
|---|---|
| HBD Count | 2 |
| Rotatable Bond | 3 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 504764186 |
|---|---|
| 分子类型 | 小分子 |
| IIUPAC Name | 5-[(E)-2-phenylethenyl]-2-propan-2-ylbenzene-1,3-diol |
| INCHI | 1S/C17H18O2/c1-12(2)17-15(18)10-14(11-16(17)19)9-8-13-6-4-3-5-7-13/h3-12,18-19H,1-2H3/b9-8+ |
| InChi Key | ZISJNXNHJRQYJO-CMDGGOBGSA-N |
| Smiles | CC(C)C1=C(C=C(C=C1O)C=CC2=CC=CC=C2)O |
| Isomeric SMILES | CC(C)C1=C(C=C(C=C1O)/C=C/C2=CC=CC=C2)O |
| 分子量 | 254.32 |
| 溶解性 | Solubility (25°C) In vitro DMSO: 51 mg/mL (200.53 mM); Ethanol: 51 mg/mL (200.53 mM); Water: Insoluble; |
|---|---|
| 敏感性 | 对光敏感 |
| DMSO(mg / mL) Max Solubility | 51 |
| DMSO(mM) Max Solubility | 200.534759358289 |
| Water(mg / mL) Max Solubility | <1 |
| 熔点 | 148 °C |
| 分子量 | 254.320 g/mol |
| XLogP3 | 4.600 |
| 氢键供体数Hydrogen Bond Donor Count | 2 |
| 氢键受体数Hydrogen Bond Acceptor Count | 2 |
| 可旋转键计数Rotatable Bond Count | 3 |
| 精确质量Exact Mass | 254.131 Da |
| 单同位素质量Monoisotopic Mass | 254.131 Da |
| 拓扑极表面积Topological Polar Surface Area | 40.500 Ų |
| 重原子数Heavy Atom Count | 19 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 280.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 1 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 1 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 象形图 | GHS09 |
|---|---|
| 信号词 | 警告 |
| 危险声明 |
H400: 对水生生物有剧毒 H410: 对水生生物有剧毒并具有长期持续影响 |
| 预防措施声明 |
P273: 避免释放到环境中。 P391: 收集溢出物 P501: 将内容物/容器处理到。。。 |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | T414465 | |
| 分析证书 | T414465 | |
| 分析证书 | T414465 | |
| 分析证书 | T414465 | |
| 分析证书 | T414465 | |
| 分析证书 | T414465 | |
| 分析证书 | T414465 | |
| 分析证书 | T414465 | |
| 分析证书 | T414465 | |
| 分析证书 | T414465 | |
| 分析证书 | T414465 | |
| 分析证书 | T414465 |
¥576.72
| 1. Bissonnette R, Bolduc C, Maari C, Nigen S, Webster JM, Tang L, Lyle M. (2012) Efficacy and safety of topical WBI-1001 in patients with mild to moderate psoriasis: results from a randomized double-blind placebo-controlled, phase II trial.. J Eur Acad Dermatol Venereol, 26 (12): (1516-21). [PMID:22077962] |
| 2. Smith SH, Jayawickreme C, Rickard DJ, Nicodeme E, Bui T, Simmons C, Coquery CM, Neil J, Pryor WM, Mayhew D et al.. (2017) Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans.. J Invest Dermatol, 137 (10): (2110-2119). [PMID:28595996] |
| 3. Lebwohl MG, Stein Gold L, Strober B, Papp KA, Armstrong AW, Bagel J, Kircik L, Ehst B, Hong HC, Soung J et al.. (2021) Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis.. N Engl J Med, 385 (24): (2219-2229). [PMID:34879448] |